Movement Disorders

Cover image for Movement Disorders

15 January 2007

Volume 22, Issue 2

Pages 155–296

  1. Reviews

    1. Top of page
    2. Reviews
    3. Research Articles
    4. Brief Reports
    5. Letters to the Editors
    6. Continuing Medical Education
  2. Research Articles

    1. Top of page
    2. Reviews
    3. Research Articles
    4. Brief Reports
    5. Letters to the Editors
    6. Continuing Medical Education
    1. Assessing the role of DRD5 and DYT1 in two different case–control series with primary blepharospasm (pages 162–166)

      Jordi Clarimon, Francesco Brancati, Elizabeth Peckham, Enza Maria Valente, Bruno Dallapiccola, Giovanni Abruzzese, Paolo Girlanda, Giovanni Defazio, Alfredo Berardelli, Mark Hallett and Andrew B. Singleton

      Version of Record online: 28 NOV 2006 | DOI: 10.1002/mds.21182

    2. Regional metabolic changes in Parkinsonian patients with normal dopaminergic imaging (pages 167–173)

      Thomas Eckert, Andrew Feigin, Daniel E. Lewis, Vijay Dhawan, Steven Frucht and David Eidelberg

      Version of Record online: 28 NOV 2006 | DOI: 10.1002/mds.21185

    3. Abnormal responses to repetitive transcranial magnetic stimulation in multiple system atrophy (pages 174–178)

      Wolfgang N. Löscher, Michaela Stampfer-Kountchev, Martin Sawires, Klaus Seppi, Joerg Mueller, Christoph Szubski, Katrin Hirnsperger, Christian Brenneis, Werner Poewe and Gregor K. Wenning

      Version of Record online: 28 NOV 2006 | DOI: 10.1002/mds.21242

    4. Sarizotan as a treatment for dyskinesias in Parkinson's disease: A double-blind placebo-controlled trial (pages 179–186)

      Christopher G. Goetz, Philippe Damier, Christine Hicking, Eugene Laska, Thomas Müller, C. Warren Olanow, Olivier Rascol and Hermann Russ

      Version of Record online: 8 NOV 2006 | DOI: 10.1002/mds.21226

    5. Substantia nigra hypoechogenicity: Definition and findings in restless legs syndrome (pages 187–192)

      Jana Godau, Katherine J. Schweitzer, Inga Liepelt, Christian Gerloff and Daniela Berg

      Version of Record online: 28 NOV 2006 | DOI: 10.1002/mds.21230

    6. Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders (pages 193–197)

      Christopher Kenney, Christine Hunter and Joseph Jankovic

      Version of Record online: 28 NOV 2006 | DOI: 10.1002/mds.21222

    7. Phenomenology of dreams in Parkinson's disease (pages 198–202)

      Leora L. Borek, Robert Kohn and Joseph H. Friedman

      Version of Record online: 28 NOV 2006 | DOI: 10.1002/mds.21255

    8. Progression of tremor and ataxia in male carriers of the FMR1 premutation (pages 203–206)

      Maureen A. Leehey, Elizabeth Berry-Kravis, Sung-Joon Min, Deborah A. Hall, Cathlin D. Rice, Lin Zhang, Jim Grigsby, Claudia M. Greco, Ann Reynolds, Rebecca Lara, Jennifer Cogswell, Sebastien Jacquemont, David R. Hessl, Flora Tassone, Randi Hagerman and Paul J. Hagerman

      Version of Record online: 28 NOV 2006 | DOI: 10.1002/mds.21252

    9. Family-based association study of the restless legs syndrome loci 2 and 3 in a European population (pages 207–212)

      David Kemlink, Olli Polo, Pasquale Montagna, Federica Provini, Karin Stiasny-Kolster, Wolfgang Oertel, Al de Weerd, Sona Nevsimalova, Karel Sonka, Birgit Högl, Birgit Frauscher, Werner Poewe, Claudia Trenkwalder, Peter P. Pramstaller, Luigi Ferini-Strambi, Marco Zucconi, Eric Konofal, Isabelle Arnulf, Georgios M. Hadjigeorgiou, Svenja Happe, Christine Klein, Anja Hiller, Peter Lichtner, Thomas Meitinger, Betram Müller-Myshok and Juliane Winkelmann

      Version of Record online: 28 NOV 2006 | DOI: 10.1002/mds.21254

    10. Efficacy of pramipexole in restless legs syndrome: A six-week, multicenter, randomized, double-blind study (effect-RLS study) (pages 213–219)

      Wolfgang H. Oertel, Karin Stiasny-Kolster, Bettina Bergtholdt, Yngve Hallström, Jaan Albo, Lena Leissner, Thomas Schindler, Juergen Koester and Juergen Reess

      Version of Record online: 28 NOV 2006 | DOI: 10.1002/mds.21261

    11. Lower urinary tract symptoms and bladder control in advanced Parkinson's disease: Effects of deep brain stimulation in the subthalamic nucleus (pages 220–225)

      Kristian Winge, Kurt Krøyer Nielsen, Hans Stimpel, Annemette Lokkegaard, Steen Rusborg Jensen and Lene Werdelin

      Version of Record online: 28 NOV 2006 | DOI: 10.1002/mds.21253

  3. Brief Reports

    1. Top of page
    2. Reviews
    3. Research Articles
    4. Brief Reports
    5. Letters to the Editors
    6. Continuing Medical Education
    1. Hypomyelinating leukoencephalopathy with paroxysmal tonic upgaze and absence of psychomotor development (pages 226–230)

      Lubov Blumkin, Dorit Lev, Nathan Watemberg and Tally Lerman-Sagie

      Version of Record online: 5 DEC 2006 | DOI: 10.1002/mds.21277

    2. Asynchronous blepharospasm, facial and cervical dystonia, and bilateral asynchronous hemifacial spasm (pages 231–233)

      Bradley J. Katz, John R. Burroughs, Richard L. Anderson, Shannon Bownds and John D. McCann

      Version of Record online: 28 NOV 2006 | DOI: 10.1002/mds.21221

    3. Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: A reader-blinded monocenter echocardiography study (pages 234–237)

      Susann Junghanns, Joerg T. Fuhrmann, Gregor Simonis, Christian Oelwein, Rainer Koch, Ruth H. Strasser, Heinz Reichmann and Alexander Storch

      Version of Record online: 8 NOV 2006 | DOI: 10.1002/mds.21225

    4. Pyramidal tract degeneration in multiple system atrophy: The relevance of magnetization transfer imaging (pages 238–243)

      Antonio José da Rocha, Antonio Carlos Martins Maia Jr., Carlos Jorge da Silva, Flávio Túlio Braga, Nelson Paes Diniz Fortes Ferreira, Orlando Graziani Povoas Barsottini and Henrique Ballalai Ferraz

      Version of Record online: 28 NOV 2006 | DOI: 10.1002/mds.21229

    5. Phenotypic variation among brothers with the McLeod neuroacanthocytosis syndrome (pages 244–247)

      Ruth H. Walker, Hans H. Jung, François Tison, Soohee Lee and Adrian Danek

      Version of Record online: 28 NOV 2006 | DOI: 10.1002/mds.21224

    6. Multiple system atrophy in a patient with the spinocerebellar ataxia 3 gene mutation (pages 251–253)

      Melissa J. Nirenberg, Jenny Libien, Jean-Paul Vonsattel and Stanley Fahn

      Version of Record online: 28 NOV 2006 | DOI: 10.1002/mds.21231

    7. R1514Q substitution in Lrrk2 is not a pathogenic Parkinson's disease mutation (pages 254–256)

      William C. Nichols, Diane K. Marek, Michael W. Pauciulo, Nathan Pankratz, Cheryl A. Halter, Alice Rudolph, Clifford W. Shults, Joanne Wojcieszek and Tatiana Foroud

      Version of Record online: 5 DEC 2006 | DOI: 10.1002/mds.21233

    8. Mortality in patients with Parkinson's disease treated by stimulation of the subthalamic nucleus (pages 257–261)

      Michael W.M. Schüpbach, Marie Laure Welter, Anne Marie Bonnet, Alexis Elbaz, Brandon R. Grossardt, Valerie Mesnage, Jean Luc Houeto, David Maltête, Luc Mallet, Walter A. Rocca, Alain Mallet and Yves Agid

      Version of Record online: 5 DEC 2006 | DOI: 10.1002/mds.21264

    9. Joubert syndrome surviving to adulthood associated with a progressive movement disorder (pages 262–264)

      Steven A. Gunzler, A. Jon Stoessl, Robert A. Egan, Richard G. Weleber, Paul Wang and John G. Nutt

      Version of Record online: 5 DEC 2006 | DOI: 10.1002/mds.21263

    10. Spinocerebellar ataxia 14: Novel mutation in exon 2 of PRKCG in a German family (pages 265–267)

      Dagmar Nolte, Melanie Landendinger, Eberhard Schmitt and Ulrich Müller

      Version of Record online: 5 DEC 2006 | DOI: 10.1002/mds.21269

    11. Auditory startle reaction in primary blepharospasm (pages 268–271)

      Jörg Müller, Martina Rinnerthaler, Werner Poewe and Markus Kofler

      Version of Record online: 5 DEC 2006 | DOI: 10.1002/mds.21270

    12. Holmes-like tremor of the lower extremity following brainstem hemorrhage (pages 272–274)

      Melanie Walker, Hojoong Kim and Ali Samii

      Version of Record online: 5 DEC 2006 | DOI: 10.1002/mds.21271

    13. Neuropathology of Parkinson's disease associated with the LRRK2 Ile1371Val mutation (pages 275–278)

      Maria Teresa Giordana, Carla D'Agostino, Giovanni Albani, Alessandro Mauro, Alessio Di Fonzo, Angelo Antonini and Vincenzo Bonifati

      Version of Record online: 5 DEC 2006 | DOI: 10.1002/mds.21281

    14. A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor (pages 279–282)

      Theresa A. Zesiewicz, Christopher L. Ward, Robert A. Hauser, Juan Sanchez-Ramos, Joseph F. Staffetti and Kelly L. Sullivan

      Version of Record online: 5 DEC 2006 | DOI: 10.1002/mds.21282

  4. Letters to the Editors

    1. Top of page
    2. Reviews
    3. Research Articles
    4. Brief Reports
    5. Letters to the Editors
    6. Continuing Medical Education
    1. Occupational dystonia affecting truncal muscles in a bricklayer (pages 284–285)

      William Baek and Geoffrey Sheean

      Version of Record online: 6 NOV 2006 | DOI: 10.1002/mds.21215

    2. Bilateral hemifacial spasm and trigeminal neuralgia: A unique form of painful tic convulsif (pages 285–286)

      Andre Carvalho Felicio, Clecio de Oliveira Godeiro Jr, Vanderci Borges, Sonia Maria de Azevedo Silva and Henrique Ballalai Ferraz

      Version of Record online: 2 NOV 2006 | DOI: 10.1002/mds.21202

    3. Dopaminergic innervation of the human striatum in Parkinson's disease (pages 286–288)

      Spiridon Papapetropoulos, Margaret Basel and Deborah C. Mash

      Version of Record online: 2 NOV 2006 | DOI: 10.1002/mds.21196

    4. Dyskinesia induced by gabapentin in idiopathic Parkinson's disease (pages 288–289)

      Prasanth M. Raju, Richard W. Walker and Mark A. Lee

      Version of Record online: 6 NOV 2006 | DOI: 10.1002/mds.21209

    5. Botulinum toxin type A therapy in a patient with cervical dystonia and amyotrophic lateral sclerosis (page 289)

      Carlos Singer, Spiridon Papapetropaulos, D. Ram Ayyar and Ashok Verma

      Version of Record online: 8 NOV 2006 | DOI: 10.1002/mds.21213

    6. Patient with late-onset Wilson's disease: Deterioration with penicillamine (pages 290–291)

      Melis Sohtaoglu, Hayal Ergin, Sibel Özekmekçi, Selim Gökdemir, Abdullah Sonsuz and Ceyhun Arici

      Version of Record online: 2 NOV 2006 | DOI: 10.1002/mds.21201

    7. Global distribution and reduced penetrance: Lrrk2 R1441C in an Irish Parkinson's disease kindred (pages 291–292)

      David Gosal, Timothy Lynch, Owen A. Ross, Kristoffer Haugarvoll, Matthew J. Farrer and J. Mark Gibson

      Version of Record online: 6 NOV 2006 | DOI: 10.1002/mds.21200

    8. Drug discarding: A problematic therapeutic event in Parkinson's disease (page 293)

      Hideto Miwa, Yasuhiro Hiwatani and Tomoyoshi Kondo

      Version of Record online: 2 NOV 2006 | DOI: 10.1002/mds.21190

    9. The ups and downs of α-synuclein mRNA expression (pages 293–295)

      Justus C. Dächsel, Sarah J. Lincoln, John Gonzalez, Owen A. Ross, Dennis W. Dickson and Matthew J. Farrer

      Version of Record online: 8 NOV 2006 | DOI: 10.1002/mds.21223

  5. Continuing Medical Education

    1. Top of page
    2. Reviews
    3. Research Articles
    4. Brief Reports
    5. Letters to the Editors
    6. Continuing Medical Education
    1. Continuing medical education (page 296)

      Version of Record online: 29 JAN 2007 | DOI: 10.1002/mds.21403

SEARCH

SEARCH BY CITATION